Ignite Creation Date:
2025-12-24 @ 11:41 PM
Ignite Modification Date:
2026-03-22 @ 2:42 AM
Study NCT ID:
NCT01365351
Status:
COMPLETED
Last Update Posted:
2017-06-02
First Post:
2011-06-01
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Online Surveillance of Treatment of Children With Growth Hormone Deficiency With ZOMACTON
Sponsor:
Ferring Pharmaceuticals
Organization:
Study Overview
Official Title:
Non-interventional Study With ZOMACTON in Children With Growth Hormone Deficiency
Status:
COMPLETED
Status Verified Date:
2017-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to investigate long-term treatment with Zomacton® for pituitary short stature in children with insufficient growth hormone production and/or short stature caused by Turner syndrome.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: